@dansfera: That feeling of absolute conviction in a cutting-edge biotech play? It's a dangerous high. Even when the science checks every box, there are lurking tripwires that make going all in a recipe for disaster. Unpredictable regulatory hurdles from the FDA, disruptive citizen's petitions, or even a frivolous intellectual property lawsuit can suddenly halt progress and drain crucial capital. Real strategy means respecting those external unknowns—protecting your portfolio from the sector's inherent volatility is non-negotiable. Smart money keeps an exit door open. #BiotechStocks #InvestingTips #StockMarket #RiskManagement #SpeculativeStocks